サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1514016

末梢動脈疾患（PAD）治療薬の世界市場

Peripheral Arterial Disease (PAD) Therapeutics

出版日
ページ情報
英文 188 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
末梢動脈疾患（PAD）治療薬の世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

末梢動脈疾患（PAD）治療薬の世界市場は2030年までに78億米ドルに到達

2023年に48億米ドルと推定される末梢動脈疾患（PAD）治療薬の世界市場は、分析期間2023-2030年にCAGR 7.0%で成長し、2030年には78億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである末梢ステントは、CAGR 6.8%を記録し、分析期間終了時には18億米ドルに達すると予測されます。末梢血管形成術用バルーンセグメントの成長率は、分析期間中CAGR 6.3%と推定されます。

米国市場は13億米ドル、中国はCAGR 6.6%で成長予測

米国の末梢動脈疾患（PAD）治療薬市場は2023年に13億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに12億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは6.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.2%と5.8%と予測されています。欧州では、ドイツがCAGR 5.4%で成長すると予測されています。

世界の末梢動脈疾患（PAD）治療薬市場- 主要動向と促進要因まとめ

末梢動脈疾患（PAD）は、特に糖尿病患者や喫煙者を含む40歳以上の人々に広く見られる健康問題であり、米国だけでも約720万人が罹患しています。PADは、運動能力の低下や痛みによって生活の質に大きな影響を与え、動脈硬化性疾患との関連によって死亡リスクを高める。無症状のものから、疼痛や潰瘍を特徴とする重症の虚血肢まで、その症状はさまざまです。多くの場合、無症候性であるにもかかわらず、無症候性患者は依然として機能的能力の低下を示し、症状のある患者と同様の虚血リスクに直面しており、症状と基礎にある動脈硬化性リスクの両方に取り組む包括的戦略の必要性を強調しています。

PADにおける治療の進歩は、心血管リスクを軽減し、重症例における跛行症状や組織喪失を管理する多方面からのアプローチに焦点を当ててきました。しかし、PADに特化したエビデンスがないため、他の心血管系疾患からの外挿データに依存しています。一般的な治療には、スタチン、抗血小板薬、アンジオテンシン変換酵素阻害薬などがあり、これらは主に冠動脈または脳血管研究からのエビデンスによって裏付けられています。抗血小板療法は冠動脈疾患の管理において確立されているが、PADに特異的なその有効性はあまり確実ではなく、治療ガイドラインを改良するためにPADに特異的な研究が必要であることを示しています。一方、無症候性症例に対しては、アスピリンやクロピドグレルのような抗血小板療法が、その有効性をめぐって議論があるにもかかわらず推奨されており、その包括的な有益性に関する調査が現在進行中であることを強調しています。

PAD治療薬市場の重要な成長促進要因には、早期かつ正確な疾患検出を強化する超音波二重層法や磁気共鳴血管造影法のような画像診断の技術進歩が含まれます。糖尿病や肥満などの生活習慣病の有病率の上昇もPAD症例を増加させ、効果的な治療に対する需要を押し上げています。教育キャンペーンやスクリーニング・プログラムを通じた一般市民や医療関係者の意識の高まりは、医薬品開発や個別化医療における技術革新とともに、従来のPAD治療アプローチの限界を押し広げつつあります。さらに、低侵襲治療への動向、もともと他の心血管系疾患のために開発された薬剤の適応拡大、進化する医療政策と償還シナリオが治療パラダイムを再構築し、PADの管理における新規治療薬の採用を促進しています。

調査対象企業の例（注目の32社）

  • AstraZeneca Plc.
  • Bayer HealthCare Pharmaceuticals
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Proteon Therapeutics, Inc.
  • Sanofi S.A.
  • Symic Bio, Inc.
  • TheraVasc, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP-6815

Global Peripheral Arterial Disease (PAD) Therapeutics Market to Reach US$7.8 Billion by 2030

The global market for Peripheral Arterial Disease (PAD) Therapeutics estimated at US$4.8 Billion in the year 2023, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Peripheral Angioplasty Balloons segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 6.6% CAGR

The Peripheral Arterial Disease (PAD) Therapeutics market in the U.S. is estimated at US$1.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.2% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Peripheral Arterial Disease (PAD) Therapeutics Market - Key Trends and Drivers Summarized

Peripheral Artery Disease (PAD) is a widespread health issue, especially among individuals over 40 years old, including those with diabetes mellitus and smokers, with about 7.2 million affected in the U.S. alone. PAD significantly impacts quality of life through reduced mobility and pain, and increases mortality risk due to its connection with atherosclerotic disease. It varies in manifestation from asymptomatic cases to severe limb ischemia characterized by pain and ulcers. Despite often being symptom-free, asymptomatic patients still exhibit decreased functional capacity and face similar ischemic risks as those with symptoms, underlining the need for comprehensive strategies that tackle both symptoms and underlying atherosclerotic risks.

Treatment advancements in PAD have focused on multi-pronged approaches that reduce cardiovascular risks and manage claudication symptoms and tissue loss in critical cases. However, the lack of specific PAD-focused evidence has led to reliance on extrapolated data from other cardiovascular conditions. Common treatments include statins, antiplatelets, and angiotensin-converting enzyme inhibitors, largely supported by evidence from coronary or cerebrovascular studies. Although antiplatelet therapy is established in managing coronary diseases, its efficacy specifically for PAD is less certain, indicating a need for PAD-specific research to refine treatment guidelines. Meanwhile, for asymptomatic cases, antiplatelet therapies like aspirin and clopidogrel are recommended despite debates over their effectiveness, highlighting an ongoing investigation into their comprehensive benefits.

Significant growth drivers in the PAD therapeutics market include technological advancements in diagnostic imaging, like duplex ultrasound and magnetic resonance angiography, which enhance early and accurate disease detection. The rising prevalence of lifestyle diseases such as diabetes and obesity also escalates PAD cases, boosting demand for effective treatments. Increased public and medical awareness through educational campaigns and screening programs, along with innovations in drug development and personalized medicine, are pushing the boundaries of traditional PAD treatment approaches. Moreover, the trend towards minimally invasive procedures, expansion of drug indications originally developed for other cardiovascular conditions, and evolving healthcare policies and reimbursement scenarios are reshaping treatment paradigms, fostering greater adoption of novel therapeutics in the management of PAD.

Select Competitors (Total 32 Featured) -

  • AstraZeneca Plc.
  • Bayer HealthCare Pharmaceuticals
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Proteon Therapeutics, Inc.
  • Sanofi S.A.
  • Symic Bio, Inc.
  • TheraVasc, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Peripheral Arterial Disease (PAD) Therapeutics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of PAD Throws the Spotlight on Therapeutic Needs
    • Increasing Aging Population Expands Addressable Market Opportunity
    • Advancements in Drug Delivery Systems Drive Adoption of PAD Therapeutics
    • Innovations in Minimally Invasive Procedures Spur Market Growth
    • Development of Novel Antiplatelet Agents Generates Demand for Advanced Therapies
    • Increased Focus on Personalized Medicine Drives Adoption of Targeted Treatments
    • Technological Innovations in Imaging and Diagnostic Tools Expand Market Potential
    • Rising Healthcare Expenditure and Access to Treatment Propel Market Expansion
    • Emergence of Combination Therapies Generates New Opportunities for PAD Treatment
    • Patent Expirations and Generic Competition Affect Market Dynamics
    • Adoption of Digital Health Technologies Drives Market Adoption
    • Growing Importance of Vascular Health Awareness Campaigns Strengthens Market Demand
    • Innovations in Stem Cell and Gene Therapies Propel Growth in PAD Therapeutics
    • Expanding Applications of PAD Therapeutics in Other Vascular Diseases Drive Market Growth
    • Advancements in Biomarker Discovery and Diagnostics Sustain Market Growth
    • Integration with Telemedicine and Remote Monitoring Generates Market Opportunities
    • Technological Convergence with Other Therapeutic Modalities Expands Market Potential
    • Challenges in Clinical Trials and Regulatory Hurdles Impact the Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Peripheral Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Peripheral Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Peripheral Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Peripheral Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Plaque Modification Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Inferior Vena Cava (IVC) Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Inferior Vena Cava (IVC) Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Inferior Vena Cava (IVC) Filters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Hemodynamic Flow Alteration Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Peripheral Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Peripheral Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Peripheral Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Peripheral Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Peripheral Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Peripheral Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Peripheral Arterial Disease (PAD) Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
  • JAPAN
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
  • CHINA
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
  • EUROPE
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Europe 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 44: France Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: France Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: France 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
  • GERMANY
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 47: Germany Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Germany Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Germany 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Italy 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 53: UK Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: UK Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: UK 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Rest of Europe 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of World Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Rest of World 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030

IV. COMPETITION